Home › Calculator › RVMDW Dividend Calculator 2026
RVMDW Dividend DRIP Calculator 2026
22.30% YieldHealthcareRevolution Medicines, Inc. Warrant · NASDAQ
Price: $8.97 · Annual div: $2.00/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD
Calculator settings
Portfolio growth: DRIP vs No DRIP
Annual dividend income growth
💡 What-if scenarios
Click to apply scenario to the calculator
🎯 When RVMDW pays your bills
Year your monthly dividend income covers each expense (based on current settings)
Share your RVMDW snowball 📈
$10,000 in RVMDW → $1911511.11M in 10 years · $158,597,952,244.07/month
About Revolution Medicines, Inc. Warrant (RVMDW) — Dividend Analysis 2026
Revolution Medicines, Inc. is a biopharmaceutical company in the clinical development phase, concentrating on creating innovative, precisely targeted therapies for cancers driven by RAS pathway dysregulation. The firm's drug development portfolio features both RAS(ON) inhibitors, which are designed for potential use as single agents, in conjunction with other RAS(ON) inhibitors, or alongside RAS companion inhibitors and various therapeutic compounds. Additionally, its pipeline includes dedicated RAS companion inhibitors intended for synergistic treatment approaches. Among its RAS(ON) inhibitors currently in Phase 1 clinical trials are RMC-6236 (targeting a broad spectrum of RAS mutations), RMC-6291 (specific to G12C), and RMC-9805 (for G12D). Further compounds in preclinical or early development include RMC-5127 (for G12V), RMC-0708 (for Q61H), and RMC-8839 (for G13C), along with ongoing programs focused on G12R and other distinct molecular targets. In the realm of RAS companion inhibitors, RMC-4630 is advancing through Phase 2 clinical assessment, while RMC-5552 is undergoing Phase 1 evaluation. Revolution Medicines, Inc. was founded in 2014 and operates from its headquarters in Redwood City, California.
Compare RVMDW with similar stocks
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
Get Your Full RVMDW DRIP Report by Email
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open RVMDW position with:
🌍 RVMDW Yield by Country & Account Type
Real after-tax yield depends on where you live and how you hold RVMDW.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 22.30% | 19.50% | $2,230 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 18.96% | 16.16% | $1,896 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 17.84% | 15.04% | $1,784 / yr |
| 🇬🇧 UK ISA | 0% | 22.30% | 19.50% | $2,230 / yr |
| 🇬🇧 UK Taxable | 8.75% | 20.35% | 17.55% | $2,035 / yr |
| 🇨🇦 TFSA | 0% | 22.30% | 19.50% | $2,230 / yr |
| 🇨🇦 CA Taxable | 25% | 16.73% | 13.93% | $1,673 / yr |
| 🇦🇺 Super (pension) | 15% | 18.96% | 16.16% | $1,896 / yr |
| 🇦🇺 AU Taxable | 30% | 15.61% | 12.81% | $1,561 / yr |
| 🇩🇪 DE Taxable | 26.375% | 16.42% | 13.62% | $1,642 / yr |
| 🇫🇷 FR Taxable | 30% | 15.61% | 12.81% | $1,561 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
🎯 RVMDW Income Goal & Break-Even
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
📅 RVMDW Dividend Payment Schedule
RVMDW pays quarterly — 4 times per year. Next ex-div: TBD.
📊 RVMDW vs Healthcare Benchmarks
How RVMDW compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for RVMDW sourced from FMP /financial-growth endpoint — real data, not estimates.
🏛️ RVMDW Insider Activity
When executives buy their own stock, it's a signal they believe in the dividend's sustainability.
| Insider | Title | Type | Date | Shares | Price | Total Value |
|---|---|---|---|---|---|---|
| M-Exempt | 2026-06-29 | 2,955 | $37.54 | $110.9K | ||
| Sale | 2026-06-29 | 300 | $183.17 | $55.0K | ||
| Sale | 2026-06-29 | 900 | $184.59 | $166.1K | ||
| Sale | 2026-06-29 | 1,100 | $185.90 | $204.5K | ||
| Sale | 2026-06-29 | 858 | $186.92 | $160.4K | ||
| Sale | 2026-06-29 | 300 | $187.83 | $56.3K | ||
| Sale | 2026-06-29 | 100 | $188.57 | $18.9K | ||
| Sale | 2026-06-29 | 600 | $190.54 | $114.3K | ||
| Sale | 2026-06-29 | 541 | $191.87 | $103.8K | ||
| Sale | 2026-06-29 | 881 | $192.61 | $169.7K |
Insider transactions sourced from SEC Form 4 filings via Financial Modeling Prep. See disclaimer.
Financial Health Scores
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the RVMDW dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
Revolution Medicines, Inc. Warrant (RVMDW) is currently trading at $8.97, trading near its 52-week high. The current dividend yield is 22.30% based on an annual payout of $2.00 per share.
RVMDW (Revolution Medicines, Inc. Warrant) — 22.30% Dividend Yield Analysis
Revolution Medicines, Inc. Warrant (RVMDW) is a healthcare stock currently trading at $8.97 with a dividend yield of 22.30%. The company pays an annual dividend of $2.00 per share. The payout ratio of 50% suggests the dividend is well-covered by earnings.
- Above-average yield (22.30%) may signal elevated risk — verify sustainability.
Auto-generated from live market data. For educational purposes only — not financial advice.